The clinical value of diagnosis and treatment guidelines timely updated for prevention and control of COVID-19

doi:10.19871/j.cnki.xfcrbzz.2022.01.020

Abstract

Abstract: Analyzed the diagnosis process of a patient infected with coronavirus disease 2019(COVID-19) who visited relatives in Shenzhen, to clarified the clinical value of the diagnosis and treatment guideline for prevention and control of COVID-19. On January 21, 2020, the patient was absence of fever and no pneumonia imaging findings by CT scanning，it did not meet the diagnostic criteria for suspected cases,so the patient just be required for home quarantine and observation. However, according to the new version of guideline issued by the National Health Commission of the People’s Republic of China on January 27, 2020, the patient must be required for home quarantine and observation which clinical feature was met the diagnostic criteria for suspected cases, so the missing diagnosis and community transmission were avoided. Therefore, during the outbreak of COVID-19, the diagnosis and treatment guidelines timely updated and published by the National Health Commission of the People's Republic of China were very practical which effectively controlled the epidemic of COVID-19.

Key words: Diagnosis and treatment guideline, Update, Coronavirus disease 2019, Epidemic prevention and control, Clinical value

Wu Weigang, Yang Zhi, Ou Pengcheng, Zeng Furong, Lyu Xiaoqing, Wang Jialu, Guo Jianwei, Wu Shipin, Yang Guilin. The clinical value of diagnosis and treatment guidelines timely updated for prevention and control of COVID-19[J]. Electronic Journal of Emerging Infectious Diseases, 2022, 7(1): 100-103.

References

[1] 中华人民共和国国家卫生健康委员会. 新型冠状病毒感染的肺炎诊疗方案(试行)[EB/OL]. http://www.nhc.gov.cn/xcs/fkdt/202001/201c8b00efa340ceb97d730a6c6ad36f.shtml.
[2] 中华人民共和国国家卫生健康委员会. 新型冠状病毒感染的肺炎诊疗方案(第二版)[EB/OL]. http://www.nhc.gov.cn/jkj/s3577/202001/c67cfe29ecf1470e8c7fc47d3b751e88.shtml.
[3] 中华人民共和国国家卫生健康委员会. 新型冠状病毒感染的肺炎诊疗方案(试行第三版)[EB/OL].http://www.nhc.gov.cn/xcs/xxgzbd/202001/f492c9153ea9437bb587ce2ffcbee1f a.shtml.
[4] 中华人民共和国国家卫生健康委员会. 新型冠状病毒感染的肺炎诊疗方案(试行第四版)[EB/OL]. http://www.nhc.gov.cn/yzygj/s7653p/202001/4294563ed35b43209b31739bd0785e67.shtml.
[5] 中华人民共和国国家卫生健康委员会. 新型冠状病毒感染的肺炎诊疗方案(试行第五版)[EB/OL].http://www.nhc.gov.cn/yzygj/s7653p/202002/3b09b894ac9b4204a79db5b8912d4440.shtml.
[6] 中华人民共和国国家卫生健康委员会. 新型冠状病毒感染的肺炎诊疗方案(试行第七版)[EB/OL].http://www.nhc.gov.cn/xcs/zhengcwj/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml.
[7] 中华人民共和国国家卫生健康委员会. 新型冠状病毒感染的肺炎诊疗方案(试行第八版修订版)[EB/OL].http://www.nhc.gov.cn/yzygj/s7653p/202104/7de0b3837c8b4606a0594aeb0105232b.shtml.
[8] WI TE, NDOWA FJ, FERREYR A, et al.Diagnosing sexually transmitted infections in resource-constrained settings: challenges and ways forward[J]. J Int AIDS Soc, 2019,22(6):e25343.
[6] 罗琳, 曾晓进, 廖欣, 等. 新冠肺炎疫情期公众疾病认知、应对方式及锻炼行为调查[J]. 中国公共卫生, 2020, 36(2):156-159.
[10] SETHI N.Research and global health emergencies: On the essential role of best practice[J]. Public Health Ethics, 2018, 11(3):237-250.
[11] GUAN WJ, NI ZY, HU Y, et al.Clinical characteristics of Coronavirus Disease 2019 in China[J]. N Engl Med, 2020, 382(18): 1708-1720.
[12] 宋璐, 曾莹婷, 龚晓明, 等. COVID-19的影像学表现及鉴别诊断[J/CD]. 新发传染病电子杂志, 2020, 5(2):83-86.
[13] 郑秋婷, 卢亦波, 谭理连, 等. COVID-19临床及影像学研究进展[J/CD]. 新发传染病电子杂志, 2020, 5(2):140-144.
[14] 中华医学会影像技术分会. COVID-19放射检查方案与感染防控专家共识(试行第一版)[J/CD].新发传染病电子杂志, 2020, 5(2):65-73.
[15] INFANTE F, CASIKAR I, MENAKAYA U, et al.Rationalising the change in defining non-viability in the first trimester[J].Australas J Ultrasound Med, 2013, 16(3), 114-117.

[1]	Liu Wenhao, Yang Jinrong, Chen Yixin, Zhou Yun, Li Yinfeng, Yun Yongxing, Yang Gendong, Huang Hua. SARS-CoV-2 omicron variant strains infection: comparative analysis of clinical features in moderate group and mild/asymptomatic group and chest CT findings [J]. Electronic Journal of Emerging Infectious Diseases, 2022, 7(2): 6-10.
[2]	Liu Dong, Wang Shuaidi, Feng Mingnan, Huang Shunxing, Li Shuo, Du Xiaopeng, Liu Ya'ou, Ding Jinli. Clinical application of shelter CT in isolation area in the stage of regular COVID-19 prevention and control [J]. Electronic Journal of Emerging Infectious Diseases, 2022, 7(2): 11-14.
[3]	Jiang Xuemei, Song Yan, Chen Yan, He li, Shao Wei. Prevention and control strategies of central sterile supply department under the normalization of the COVID-19 epidemic [J]. Electronic Journal of Emerging Infectious Diseases, 2022, 7(2): 15-18.
[4]	Infectious, Inflammatory Radiology Committee of Jiangsu Research Hospital Association, Quality Control Center of Jiangsu Diagnostic Radiology, Infectious Diseases Group of Radiology Branch of Jiangsu Medical Association. Consensus of experts on radiological examination, diagnosis, prevention and control rules for coronavirus disease 2019 in Jiangsu province (2^nd Edition 2022) [J]. Electronic Journal of Emerging Infectious Diseases, 2022, 7(2): 79-88.
[5]	Liao Kangsheng, Lu Hongzhou. Current studies in 2019-nCoV Omicron variant: implications for scientific prevention and control strategies [J]. Electronic Journal of Emerging Infectious Diseases, 2022, 7(1): 1-5.
[6]	Yu Qi, Song Yan, Liu Sicong, Wang Mengmeng, Zhang Ailing. Investigation and analysis on knowledge and practice of nosocomial infection prevention and control of supporting nurses in non-infectious department [J]. Electronic Journal of Emerging Infectious Diseases, 2022, 7(1): 60-65.
[7]	Lu Hongxi, Liu Gang, Chen Xin. Analysis of virological characteristics of 2019-nCoV mutant strain concerned by WHO [J]. Electronic Journal of Emerging Infectious Diseases, 2022, 7(1): 88-91.
[8]	Zhan Xiangming, Lu Hongzhou. Research progress of the impact of COVID-19 on AIDS patients worldwide [J]. Electronic Journal of Emerging Infectious Diseases, 2021, 6(4): 356-360.
[9]	Lu Chunrong, Fang Hongxia, Lu Puxuan, Ji Lecai. The global tuberculosis report 2021: key data analysis for China and the global world [J]. Electronic Journal of Emerging Infectious Diseases, 2021, 6(4): 368-372.
[10]	Lu Qian, Gao Shitong, Liu Qu, Zhang Zhongming. Investigation, analysis and diagnosis of an imported COVID-19 case with ovale malaria in Guangdong Province [J]. Electronic Journal of Emerging Infectious Diseases, 2021, 6(3): 177-180.
[11]	Chen Qiuqi, Deng Guofang. WHO interpretation of guidelines for COVID-19 considerations for tuberculosis (TB) care [J]. Electronic Journal of Emerging Infectious Diseases, 2021, 6(3): 265-269.
[12]	Yang Zhongping, Qin Yuanyuan, Zhou Yihong, Chen Yaokai. Clinical features and prognosis of COVID-19 among people living with HIV: a systematic literature analysis [J]. Electronic Journal of Emerging Infectious Diseases, 2021, 6(2): 113-118.
[13]	Shao Wei, Zhang Li, Chen Yan, Huang Ying, Wang Wenhui, Zhang Lijun, Sha Li. Application effect of HFMEA model in the prevention and control of nosocomial infection of coronavirus disease 2019 [J]. Electronic Journal of Emerging Infectious Diseases, 2021, 6(2): 129-132.
[14]	Li Shikang, Li Zhuo, Xu Ruiqing, Yan Xiaofeng, Li Jianhua, Lyu Liang, Song Yuyan, Sun Qiangzhong, Li Tongxin, Qian Lanlan, Zhang Ying. Multimodal deep learning for predicting COVID-19 patients at high-risk for serious illness [J]. Electronic Journal of Emerging Infectious Diseases, 2021, 6(2): 133-137.
[15]	Huang Bin, Gao Bo. The impact of COVID-19 on the nervous system [J]. Electronic Journal of Emerging Infectious Diseases, 2021, 6(2): 155-159.